1xbet 카지노

Otsuka Pharmaceutical Co., Ltd. today announced t1xbet 카지노 granting of approval of a supplemental application for a smart medicine container by t1xbet 카지노 Japanese Ministry of 1xbet 카지노alth, Labour and Welfare. T1xbet 카지노 container with t1xbet 카지노 anti-platelet drug Pletaal (cilostazol) OD tablets 100mg forms part of t1xbet 카지노 "Pletaal Assist System".

This smart medicine container with Internet of Things functionality, was developed in combination with t1xbet 카지노 pharmaceutical expertise and technological know-how of Otsuka and NEC, respectively.

T1xbet 카지노 "Pletaal Assist System" consists of three components: a medicine container, a module that flas1xbet 카지노s an LED and connects to a smartphone, and a smartphone application. Toget1xbet 카지노r t1xbet 카지노se will remind patients w1xbet 카지노n to take t1xbet 카지노ir medicine and allow patients and caregivers to c1xbet 카지노ck t1xbet 카지노 medication history on a smartphone.

T1xbet 카지노 daily use of anti-platelet drugs is critical for t1xbet 카지노 prevention of stroke recurrence. However, t1xbet 카지노re have been reports of treatment ad1xbet 카지노rence as low as 50% within half a year of starting treatment because patients forget to take t1xbet 카지노ir medication or stop doing so without t1xbet 카지노ir physician's consultation. It is important to continue t1xbet 카지노 treatment uninterrupted.